Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
07 2022
Historique:
received: 17 01 2022
accepted: 26 04 2022
pubmed: 28 6 2022
medline: 15 7 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

Memory B cells persist for a lifetime and rapidly differentiate into antibody-producing plasmablasts and plasma cells upon antigen re-encounter. The clonal relationship and evolution of memory B cells and circulating plasmablasts is not well understood. Using single-cell sequencing combined with isolation of specific antibodies, we found that in two healthy donors, the memory B cell repertoire was dominated by large IgM, IgA and IgG2 clonal families, whereas IgG1 families, including those specific for recall antigens, were of small size. Analysis of multiyear samples demonstrated stability of memory B cell clonal families and revealed that a large fraction of recently generated plasmablasts was derived from long-term memory B cell families and was found recurrently. Collectively, this study provides a systematic description of the structure, stability and dynamics of the human memory B cell pool and suggests that memory B cells may be active at any time point in the generation of plasmablasts.

Identifiants

pubmed: 35761085
doi: 10.1038/s41590-022-01230-1
pii: 10.1038/s41590-022-01230-1
pmc: PMC9276532
doi:

Substances chimiques

Immunoglobulin G 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1076-1085

Informations de copyright

© 2022. The Author(s).

Références

Curr Opin Immunol. 2020 Apr;63:1-6
pubmed: 31639539
J Exp Med. 2018 Aug 6;215(8):2035-2053
pubmed: 29959173
Mol Biol Evol. 1997 Jul;14(7):685-95
pubmed: 9254330
Science. 2002 Dec 13;298(5601):2199-202
pubmed: 12481138
Nature. 2019 Feb;566(7744):398-402
pubmed: 30760926
Annu Rev Immunol. 2012;30:429-57
pubmed: 22224772
Blood. 2005 Feb 15;105(4):1614-21
pubmed: 15507523
Life Sci Alliance. 2021 Dec 24;5(3):
pubmed: 34952892
Bioinformatics. 2015 Oct 15;31(20):3356-8
pubmed: 26069265
Nat Commun. 2016 Dec 20;7:13642
pubmed: 27995928
Nature. 2014 Dec 18;516(7531):418-22
pubmed: 25296253
Nature. 2019 Feb;566(7744):393-397
pubmed: 30664748
Annu Rev Immunol. 2009;27:267-85
pubmed: 19302041
Elife. 2016 Aug 02;5:
pubmed: 27481325
Science. 2020 Oct 9;370(6513):237-241
pubmed: 32792465
PeerJ. 2016 Feb 25;4:e1720
pubmed: 26966658
J Exp Med. 1998 Nov 2;188(9):1679-89
pubmed: 9802980
Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676):
pubmed: 26194752
Cell Rep. 2020 Jan 21;30(3):905-913.e6
pubmed: 31968262
Cell Host Microbe. 2020 Oct 7;28(4):516-525.e5
pubmed: 32941787
Nature. 2008 May 29;453(7195):667-71
pubmed: 18449194
Genes Immun. 2021 Aug;22(4):205-217
pubmed: 34175903
Nat Rev Immunol. 2006 Oct;6(10):741-50
pubmed: 16977339
Nat Immunol. 2015 Jul;16(7):755-65
pubmed: 26006014
Nature. 1996 Jun 27;381(6585):751-8
pubmed: 8657279
Immunity. 2019 Aug 20;51(2):337-350.e7
pubmed: 31375460
Cell Host Microbe. 2013 Jun 12;13(6):691-700
pubmed: 23768493
Genetics. 2017 May;206(1):417-427
pubmed: 28315836
Cell. 2019 May 30;177(6):1566-1582.e17
pubmed: 31104840
Immunity. 2017 Jul 18;47(1):118-134.e8
pubmed: 28709802
Immunity. 2015 Jul 21;43(1):132-45
pubmed: 26187412
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2636-45
pubmed: 27114511
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Nat Med. 2004 Aug;10(8):871-5
pubmed: 15247913
J Immunol Methods. 2008 Jan 1;329(1-2):112-24
pubmed: 17996249
Science. 2011 Aug 12;333(6044):850-6
pubmed: 21798894
J Mol Evol. 1987;26(1-2):123-31
pubmed: 3125330
Nat Biotechnol. 2014 Feb;32(2):158-68
pubmed: 24441474
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40
pubmed: 23671333
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
J Exp Med. 2003 Apr 7;197(7):939-45
pubmed: 12682112
J Mol Evol. 1990 Dec;31(6):511-23
pubmed: 2176699
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Nat Immunol. 2016 Oct;17(10):1226-34
pubmed: 27525369

Auteurs

Ganesh E Phad (GE)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland. ganesh.phad@irb.usi.ch.

Dora Pinto (D)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.

Mathilde Foglierini (M)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.

Murodzhon Akhmedov (M)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Bigomics Analytics SA, Bellinzona, Switzerland.

Riccardo L Rossi (RL)

National Institute of Molecular Genetics, Milano, Italy.

Emilia Malvicini (E)

National Institute of Molecular Genetics, Milano, Italy.

Antonino Cassotta (A)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.

Chiara Silacci Fregni (CS)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.

Ludovica Bruno (L)

National Institute of Molecular Genetics, Milano, Italy.

Federica Sallusto (F)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Institute of Microbiology, ETH Zürich, Zurich, Switzerland.

Antonio Lanzavecchia (A)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland. lanzavecchia@ingm.org.
National Institute of Molecular Genetics, Milano, Italy. lanzavecchia@ingm.org.
Humabs BioMed, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. lanzavecchia@ingm.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH